Citation 80593

HISAMOTO,M: INAOKA,Y: SAKAIDA,Y: KAGAZAKI,T: ENOKIDA,R: OKAZAKI,T: HARUYAMA,H: KINOSHITA,T: MATSUDA,K:. (1998). A-53930A AND B, NOVEL N-TYPE CA2+ CHANNEL BLOCKERS.. 51(7)

Citation Details

Title	A-53930A AND B, NOVEL N-TYPE CA2+ CHANNEL BLOCKERS.
Authors	HISAMOTO,M: INAOKA,Y: SAKAIDA,Y: KAGAZAKI,T: ENOKIDA,R: OKAZAKI,T: HARUYAMA,H: KINOSHITA,T: MATSUDA,K:
Year	1998
Volume	51
Issue	7

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CALCIUM CHANNEL BLOCKER	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOTHRICIN F	WEAK ACTIVITY
2	CALCIUM CHANNEL BLOCKER	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOTHRICIN F	INACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOTHRICIN F	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOTHRICIN F	ACTIVE
5	DEATH	PHARMACOLOGY OF COMPOUND - IN VIVO	STREPTOTHRICIN F	ACTIVE

Streptomyces vinaceus-drappus (STREPTOMYCETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	STREPTOMYCES ANTIBIOTIC A-53930-A	None
2	CALCIUM CHANNEL BLOCKER	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC A-53930-A	ACTIVE
3	CALCIUM CHANNEL BLOCKER	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC A-53930-A	INACTIVE
4	NOREPINEPHRINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC A-53930-A	WEAK ACTIVITY
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOMYCES ANTIBIOTIC A-53930-A	WEAK ACTIVITY
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOMYCES ANTIBIOTIC A-53930-A	INACTIVE
7	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VIVO	STREPTOMYCES ANTIBIOTIC A-53930-A	ACTIVE
8	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	STREPTOMYCES ANTIBIOTIC A-53930-B	None
9	CALCIUM CHANNEL BLOCKER	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC A-53930-B	ACTIVE
10	CALCIUM CHANNEL BLOCKER	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC A-53930-B	INACTIVE
11	NOREPINEPHRINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOMYCES ANTIBIOTIC A-53930-B	WEAK ACTIVITY
12	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOMYCES ANTIBIOTIC A-53930-B	WEAK ACTIVITY
13	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOMYCES ANTIBIOTIC A-53930-B	INACTIVE
14	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VIVO	STREPTOMYCES ANTIBIOTIC A-53930-B	ACTIVE
15	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	STREPTOTHRICIN B	None
16	CALCIUM CHANNEL BLOCKER	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOTHRICIN B	ACTIVE
17	CALCIUM CHANNEL BLOCKER	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOTHRICIN B	INACTIVE
18	NOREPINEPHRINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STREPTOTHRICIN B	WEAK ACTIVITY
19	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOTHRICIN B	ACTIVE
20	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	STREPTOTHRICIN B	ACTIVE
21	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VIVO	STREPTOTHRICIN B	ACTIVE

Citation 80593

Citation Details

Summary

Organisms and Their Experiments (2)

Unknown organism

Streptomyces vinaceus-drappus (STREPTOMYCETACEAE)

Show SPARQL Queries (1)

Query 1